ICTRP Search Portal

Main

Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.

Register:	German Clinical Trials Register
Last refreshed on:	8 April 2024
Main ID:	DRKS00006881
Date of registration:	10/04/2015
Prospective Registration:	No
Primary sponsor:	Universitätsklinikum Freiburg Abteilung der Neuroradiologie
Public title:	Endovascular Treatment of Intracranial Aneurysms with Surpass Flow Diverter. A retrospective multicenter study with respect to clinical and angiographic outcome
Scientific title:	Endovascular Treatment of Intracranial Aneurysms with Surpass Flow Diverter. A retrospective multicenter study with respect to clinical and angiographic outcome - SUR-POST
Date of first enrolment:	15/10/2014
Target sample size:	53
Recruitment status:	Complete
URL:	http://drks.de/search/en/trial/DRKS00006881
Study type:	observational
Study design:	Allocation: ; Masking: ; Control: ; Assignment: ; Study design purpose: treatment
Phase:

Countries of recruitment
Argentina	Denmark	France	Germany	Hungary	Japan	Netherlands	United States

Contacts

Name:	Christian Taschner
Address:	Breisacher Straße 64 79106 Freiburg Germany
Telephone:	+49 761 270-50010
Email:	christian.taschner@uniklinik-freiburg.de
Affiliation:	Universitätsklinikum Freiburg Abteilung der Neuroradiologie

Name:	Christian Taschner
Address:	Breisacher Straße 64 79106 Freiburg Germany
Telephone:	+49 761 270-50010
Email:	christian.taschner@uniklinik-freiburg.de
Affiliation:	Universitätsklinikum Freiburg Abteilung der Neuroradiologie

Key inclusion & exclusion criteria

Inclusion criteria: Any patient that received FD treatment with Surpass for aneurysmatic disease within the posterior circulation.
Exclusion criteria: Patients < 16 years of age

Age minimum: 16 Years
Age maximum: 80 Years
Gender: All

Health Condition(s) or Problem(s) studied

I67.1

intracranial aneurysm, posterior circulation
I67.1

Cerebral aneurysm, nonruptured

Intervention(s)

Group 1: Any male or female patient between 16 and 79 years of age that received FD treatment with Surpass for aneurysmatic disease within the posterior circulation between 07/2010 and 03/2015.

Primary Outcome(s)

Mortality in patients with intracranial aneurysms of the posterior circulation after flow-diverter treatment with the Surpass flow diverter (after 12 months) and complete occlusion in angiographic follow up (after 12 months).

Secondary Outcome(s)

Technical success rate, complication rate of aneurysm treatment with the Surpass flow-diverter, new neurological deficits after 24 hours, modified Rankin Scale (mRS) at discharge and morbidity (mRS 3 till 5) at follow-up.

Secondary ID(s)

Source(s) of Monetary Support

Universitätsklinikum Freiburg Abteilung der Neuroradiologie

Secondary Sponsor(s)

Ethics review

Status: Approved
Approval date: 09/10/2014
Contact:

ekfr.mpg@uniklinik-freiburg.de

Ethik-Kommission der Albert-Ludwigs-Universität Freiburg

+49-761-27072600

ekfr.mpg@uniklinik-freiburg.de

Results

Results available:
Date Posted:
Date Completed:	15/06/2015
URL:	http://drks.de/search/en/trial/DRKS00006881#studyResults

Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.